Fiduciary Trust’s Editas Medicine EDIT Stock Holding History

Fiduciary Trust’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-36,085	Closed	-$821K	–	516
2019 Q3	$821K	Buy	36,085 +6	+0%	+$149	0.02%	295
2019 Q2	$892K	Sell	36,079 -1,000	-3%	-$23.9K	0.02%	273
2019 Q1	$907K	Sell	37,079 -40,000	-52%	-$905K	0.02%	267
2018 Q4	$1.75M	Hold	77,079	–	–	0.05%	192
2018 Q3	$2.45M	Hold	77,079	–	–	0.07%	180
2018 Q2	$2.76M	Buy	+77,079	New	+$2.73M	0.08%	162

Other funds holding EDIT

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fiduciary Trust's EDIT Position: Q4 2019 in Review

Fiduciary Trust sold out of Editas Medicine (EDIT) in Q4 2019, closing a stake of 36,085 shares — an estimated $821K sold.

Fiduciary Trust first reported a position in EDIT in Q2 2018 and held it in 6 quarters. The position peaked at $2.76M in Q2 2018. 229 funds tracked by Wall St. Rank hold EDIT as of Q4 2019.

Fiduciary Trust reported no remaining Editas Medicine position as of Q4 2019 after selling out during the quarter.
Fiduciary Trust sold 36,085 Editas Medicine shares in Q4 2019, an estimated $821K.
Fiduciary Trust first reported a position in Editas Medicine in Q2 2018 and held it in 6 quarters.
Fiduciary Trust's Editas Medicine position peaked at $2.76M in Q2 2018.
229 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2019.

Based on Fiduciary Trust's 13F filing for Q4 2019, filed 4 Feb 2020.